Since EBV can induce immune dysregulation and expression of IL-6 in peripheral blood mononuclear cells (PBMCs) via deoxyuridine triphosphate nucleotidohydrolase (dUTPase) in vitro [3], one might speculate that EBV acts as an additional inflammatory trigger in critically ill COVID-19 patients. Here, IL6 is linked to COVID-19.